Moleculin Biotech, Inc. is preclinical and clinical-stage pharmaceutical company focused on the development of game-changing anti-cancer drug candidates, many of which are based on discoveries made at M.D. Anderson Cancer Center. Each of our projects represents a breakthrough discovery and a highly disruptive technology.

Contacts

Investor Relations

PCG Advisory
Kirin M. Smith
Chief Operating Officer
T: (646) 863-6519

Transfer Agent

VStock Transfer, LLC

Auditor

Grant Thornton LLP

Legal Counsel

Schiff Hardin LLP
Cavas Pavri

Media

PCG Advisory
Sean Leous
Chief Communications Officer
T: (646) 893-8998
sleous@pcgadvisory.com